Quarterly ResultMay 7, 2026, 06:37 AM
BD Q2 Revenue $4.71B, Adj. EPS $2.90; Raises Full-Year Adj. EPS Guidance
AI Summary
Becton, Dickinson and Company (BD) reported solid financial results for its second fiscal quarter ended March 31, 2026, with revenue of $4.71 billion, a 5.2% increase, and adjusted diluted EPS of $2.90, up 3.9%. The company's performance exceeded expectations, driven by broad-based growth across its segments. BD also executed a $2.0 billion accelerated share repurchase program and retired $2.1 billion of debt. Based on its strong first-half performance, BD reaffirmed its full-year revenue growth guidance and raised its full-year adjusted diluted EPS guidance.
Key Highlights
- Q2 fiscal 2026 revenue was $4.71 billion, up 5.2% reported and 2.6% foreign currency neutral (FXN).
- Q2 adjusted diluted EPS from continuing operations was $2.90, up 3.9% reported and 1.1% FXN.
- Executed a $2.0 billion accelerated share repurchase program during the quarter.
- Retired $2.1 billion of debt in the second fiscal quarter.
- Raised full-year fiscal 2026 adjusted diluted EPS guidance to $12.52-$12.72.
- Interventional segment revenue increased 7.3% to $1.357 billion.
- Medical Essentials segment revenue grew 4.7% to $1.647 billion.
- Q2 GAAP diluted EPS from continuing operations was $(0.13), impacted by $487 million in restructuring costs.